According to Renovaro Biosciences's latest financial reports the company's current earnings (TTM) are -S$70.25 M. In 2023 the company made an earning of -S$53.71 M an increase over its 2022 earnings that were of -S$0.15 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.